Add time:08/26/2019         Source:sciencedirect.com

Continued SAR optimization of a series of 3-methylpyridine-2-carbonyl amino-2,4-dimethyl-benzoic acid led to the selection of compound 4f for clinical studies. Compound 4f showed an IC50 of 123 nM for inhibition of PGE2-induced TNFα reduction in an ex vivo LPS-stimulated human whole blood assay (showing >10-fold increase over clinical compound CJ-023,423). Pharmacokinetic profile, selectivity and in vivo efficacy comparing 4f to NSAID diclofenac in the monoiodoacetic acid (MIA) pain model and adjuvant induced arthritis (AIA) inflammatory model are included.

We also recommend Trading Suppliers and Manufacturers of BENZOIC ACID,2-AMINO-4-CHLORO-5-FLUORO- (cas 108288-16-0). Pls Click Website Link as below: cas 108288-16-0 suppliers